Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Phase 2, Randomized, Double-blinded Study to Assess the Safety, Tolerability, and Efficacy of KarXT in Hospitalized Adults With DSM-5 Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Read the official source — NCT00034775Open-Label Trial Exploring A Switching Regimen From Oral Neuroleptics, Other Than Risperidone, To Risperidone Depot Microspheres
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety of ASP4345 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleA Non-Randomized, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of LV232 Capsule Assessing Serotonin Transporter Occupancy in the Healthy Adult Brain Using 11C-DASB Positron Emission Tomography (PET)
This study has finished and is no longer accepting participants.
In ShanghaiA Sequential and Parallel Cohort Design to Test the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
This study ended early.
Multiple locations, including TorrancePhase 1b Randomized, Placebo-controlled Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Subjects With Opioid Use Disorder
This study has finished and is no longer accepting participants.
In Overland ParkA Randomized, Double-blind, Placebo-controlled, Fixed Sequence Study to Assess the Effect on Respiratory Drive of Multiple Doses of AZD4041 When Co-administered With a Single Dose of Morphine in Healthy Recreational Opioid Users
This study has finished and is no longer accepting participants.
In Overland ParkA Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
This study ended early.
In New YorkPhase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of RO6889450 (Ralmitaront) in Patients With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
This study ended early.
Multiple locations, including BellflowerA Phase 3, Multicenter, Two-part Study With a 5-week Double-blind Part (Randomized, Parallel-group, Placebo-controlled) Followed by a 12-week Open-label Extension Part, to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including HefeiResearchers compared ML-007C-MA QD, ML-007C-MA BID and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluates the safety and effectiveness of REL-1017 for people with depression.
This study ended early.
Multiple locations, including HomewoodWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.